Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Current Treatment Options in Oncology|May 2, 2023
Novel Estrogen Receptor-Targeted Agents for Breast CancerMythili Shastry, Erika HamiltonCancer Treatment Reviews|March 28, 2016
Targeting CDK4/6 in patients with cancerErika Hamilton, Jeffrey R InfanteCancer Treatment Reviews|April 6, 2023
The evolving landscape of antibody-drug conjugates in gynecologic cancersAnthony Tolcher, Erika Hamilton, Robert L ColemanNature Reviews. Drug Discovery|November 7, 2022
Targeting HER2-positive breast cancer: advances and future directionsSandra M Swain, Mythili Shastry, Erika HamiltonCancer Investigation|August 17, 2011
New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune responseErika Hamilton, Timothy M Clay, Kimberly L BlackwellExpert Review of Anticancer Therapy|June 23, 2022
Efficacy, safety and toxicity management of adjuvant abemaciclib in early stage HR+/HER2- high-risk breast cancerSarah Sammons, Heather Moore, Jaycee Cushman, et al.Breast (Edinburgh, Scotland)|October 27, 2022
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancerMythili Shastry, Saya Jacob, Hope S Rugo, et al.Cancer Treatment Reviews|September 17, 2021
Targeting HER2 heterogeneity in breast cancerErika Hamilton, Mythili Shastry, S Michelle Shiller, et al.Clinical Breast Cancer|November 30, 2019
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR+/HER2- Breast CancerSarah Sammons, Mythili Shastry, Susan Dent, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
A Big World Made Small: Using Social Media to Optimize Patient CareIshwaria M Subbiah, Erika Hamilton, Miriam Knoll, et al.Pageof 9